Could the recent "surge" in share price be from those looking at the announced new share offering actually finding value beyond the current meager market pricing for this company ?
Maybe there's something to their psoriasis trials.
If so, wouldn't that be nice for $400,000,000 in development costs for at least one commercial application.
Those at Idera have much riding, both financially and professionally, on some success besides more seemingly worthless patents, so while maybe highly motivated, they still need to be able to cross that elusive scientific bridge to create true value outside the laboratory.
I for one hope they succeed but remain quite cautious and skeptical from their history of to-date failures.
Word .... exactly the point, these guys are way over due to get off the pot ... if they dont at least double within the next 6 months ... I am going elsewhere and just cash in for a nice steak dinner and massage with a happier ending than this Tom Foolery